U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07158814) titled 'Safety of RSV Preventive Monoclonal Antibody' on Sept. 04.
Brief Summary: This is a prospective, randomized, open-label clinical trial to evaluate the safety of administration of respiratory syncytial virus (RSV) preventive monoclonal antibody and other routine childhood vaccines given simultaneously at Visit 1, as compared to sequential administration of respiratory syncytial virus (RSV) preventive monoclonal antibody and other vaccines at separate visits (Visits 1 and 2).
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Fever
Adverse Event Following Immunisation
Intervention:
DRUG: Respiratory Syncytial Vi...